Accurate analysis of S-phase fraction is crucial for the assessment of cell proliferation levels, tumor malignancy and prognostic effects of treatment. Most of the currently developed methods for S-phase cell analysis rely on flow cytometric analysis of DNA content determination. However, the lack of standardized procedures for sample analysis and interpretation of cell cycle fitting graphs poses a significant limitation in clinical practice for utilizing flow cytometry to measure the cell cycle based on DNA content. Herein, we developed an approach for analyzing S-phase cells based on telomerase activity determination. Briefly, this approach distinguishes S-phase cells in cell populations via direct fluorescence tracking of telomerase activity within individual cells. The dynamic analysis of telomerase activity in different cell cycles was made possible by the ALTMAN strategy developed in our previous studies, which has been successfully employed to distinguish S-phase cells in cultured cells. This method offers a novel avenue for the assessment of cell cycle status and the evaluation of the proliferation status of tumor cells and the prognosis effect of tumor patients via analyzing the differences in telomerase activity during different cell cycle processes.
Keyphrases
- cell cycle
- cell proliferation
- induced apoptosis
- cell cycle arrest
- signaling pathway
- single cell
- stem cells
- endoplasmic reticulum stress
- flow cytometry
- clinical practice
- cell therapy
- end stage renal disease
- chronic kidney disease
- mesenchymal stem cells
- prognostic factors
- solid phase extraction
- newly diagnosed
- liquid chromatography
- peritoneal dialysis
- data analysis
- combination therapy
- case control